GlassScriptPhysician profile
Rashmi C Tomur
NPI 1770686305
$1,548.10
in general payments reported to CMS, 2019-2025
20 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $11.74 · 2021: $296 · 2022: $141 · 2023: $295 · 2024: $341 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $204.94 | 2024-2025 | Veozah |
| Mylan Pharmaceuticals INC. | $148.37 | 2019-2021 | |
| Abbvie INC. | $145.89 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $137.78 | 2023-2024 | Myfembree |
| Organon LLC | $123.86 | 2022-2025 | Nexplanon, Nuvaring, Jada System |
| Boston Scientific Corporation | $93.02 | 2019 | |
| Roche Diagnostics Corporation | $87.21 | 2019 | |
| Agile Therapeutics, INC. | $86.57 | 2023-2024 | Twirla |
| Myovant Sciences INC. | $79.31 | 2021-2022 | |
| Exeltis, USA INC. | $72.75 | 2022-2025 | Slynd |
| Avion Pharmaceuticals | $61.55 | 2021-2023 | Balcoltra |
| Therapeuticsmd, INC. | $60.33 | 2021-2022 | |
| Pfizer INC. | $53.10 | 2023-2024 | |
| Coopersurgical, INC. | $40.97 | 2024-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $39.96 | 2019-2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $34.99 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $30.83 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Aspira Women'S Health INC | $20.09 | 2024 | Ova1 |
| Gynesonics, INC. | $15.90 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $10.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashmi Tomur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.